全文获取类型
收费全文 | 353篇 |
免费 | 16篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 8篇 |
妇产科学 | 7篇 |
基础医学 | 89篇 |
临床医学 | 37篇 |
内科学 | 54篇 |
皮肤病学 | 4篇 |
神经病学 | 9篇 |
特种医学 | 42篇 |
外科学 | 24篇 |
预防医学 | 2篇 |
眼科学 | 5篇 |
药学 | 24篇 |
肿瘤学 | 57篇 |
出版年
2016年 | 3篇 |
2015年 | 5篇 |
2013年 | 13篇 |
2012年 | 12篇 |
2011年 | 9篇 |
2010年 | 13篇 |
2009年 | 10篇 |
2008年 | 19篇 |
2007年 | 8篇 |
2006年 | 22篇 |
2005年 | 15篇 |
2004年 | 26篇 |
2003年 | 17篇 |
2002年 | 18篇 |
1998年 | 3篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 5篇 |
1979年 | 4篇 |
1976年 | 4篇 |
1967年 | 5篇 |
1966年 | 5篇 |
1965年 | 7篇 |
1961年 | 3篇 |
1959年 | 6篇 |
1958年 | 4篇 |
1956年 | 3篇 |
1955年 | 2篇 |
1954年 | 3篇 |
1943年 | 2篇 |
1942年 | 4篇 |
1941年 | 3篇 |
1939年 | 4篇 |
1938年 | 2篇 |
1937年 | 2篇 |
1936年 | 6篇 |
1935年 | 4篇 |
1934年 | 3篇 |
1933年 | 7篇 |
1932年 | 5篇 |
1931年 | 3篇 |
1928年 | 4篇 |
1927年 | 4篇 |
1926年 | 2篇 |
1925年 | 2篇 |
1921年 | 4篇 |
排序方式: 共有369条查询结果,搜索用时 15 毫秒
361.
362.
Hellmut Hartert 《Journal of molecular medicine (Berlin, Germany)》1958,36(22):1084-1084
Ohne Zusammenfassung 相似文献
363.
To investigate aging processes of silicone gel breast implants, which may include migration of free unreacted material from the gel and rubber to local (e.g. connective tissue capsule) or distant sites in the body, chemical alteration of the polymer and infiltration of body compounds, various approaches of multinuclear nuclear magnetic resonance (NMR) experiments (29Si, 13C, 1H) were evaluated. While 29Si, 13C, and 1H solid-state magic angle spinning (MAS) NMR techniques performed on virgin and explanted envelopes of silicone prostheses provided only limited information, high-resolution liquid-state NMR techniques of CDCl(3) extracts were highly sensitive analytical tools for the detection of aging related changes in the materials. Using 2D 1H, 1H correlation spectroscopy (COSY) and 29Si, 1H heteronuclear multiple bond coherence (HMBC) experiments with gradient selection, it was possible to detect lipids (mainly phospholipids) as well as silicone oligomer species in explanted envelopes and gels. Silicone oligomers were also found in connective tissue capsules, indicating that cyclic polysiloxanes can migrate from intact implants to adjacent and distant sites. Furthermore, lipids can permeate the implant and modify its chemical composition. 相似文献
364.
365.
Elmaagacli AH Peceny R Steckel N Trenschel R Ottinger H Grosse-Wilde H Schaefer UW Beelen DW 《Blood》2003,101(2):446-453
Outcomes of highly purified CD34(+) peripheral blood stem cell transplantation (PBSCT) for chronic phase chronic myeloid leukemia (CML) (n = 32) were compared with those of PBSCT (n = 19) and of bone marrow transplantation (BMT) (n = 22) in the HLA-compatible sibling donor setting. Median follow-up was 18 months after CD34(+)-PBSCT and unmanipulated PBSCT and 20 months after BMT. CD34(+)-PBSCT was associated with delayed T-cell immune reconstitution at 3 months and 12 months after transplantation compared with PBSCT (P <.001) or BMT (not significant [NS]). The estimated probability of grades II to IV acute graft-versus-host disease (GVHD) was 60% +/- 13% for the PBSCT group, 37% +/- 13% for the BMT group, and only 14% +/- 8% for the CD34(+)-PBSCT group (CD34-PBSCT versus BMT, P <.01; and CD34-PBSCT versus PBSCT, P <.001). The probabilities for molecular relapse were 88% for CD34(+)-PBSCT, 55% after BMT, and 37% after PBSCT (CD34(+)-PBSCT versus PBSCT, P <.03). Cytogenetic relapse probability was 58% after CD34(+)-PBSCT, 42% after BMT, and 28% after PBSCT (NS). After CD34(+)-PBSCT, 26 of 32 patients received a T-cell add-back. Hematologic relapse occurred in 4 of 22 patients after BMT, in 3 of 19 patients after PBSCT, and in only 1 of 32 patients after CD34(+)-PBSCT. The occurrence of a hematologic relapse in patients receiving CD34(+)-PBSC transplants was prevented by donor leukocyte infusions, which were applied at a median of 4 times (range, 1-7 times) with a median T-cell dose of 3.3 x 10(6) x kg/body weight [at a median] beginning at day 120 (range, 60-690 days). The estimated probability of 3-year survival after transplantation was 90% in the CD34(+)-PBSCT group, 68% in the PBSCT group, and 63% in the BMT group (CD34-PBSCT versus BMT, P <.01; and CD34-PBSCT versus PBSCT, P <.03). Transplantation of CD34(+)-PBSCs with T-cell add-back for patients with CML in first chronic phase seems to be safe and is an encouraging alternative transplant procedure to BMT or PBSCT. 相似文献
366.
Socié G Schmoor C Bethge WA Ottinger HD Stelljes M Zander AR Volin L Ruutu T Heim DA Schwerdtfeger R Kolbe K Mayer J Maertens JA Linkesch W Holler E Koza V Bornhäuser M Einsele H Kolb HJ Bertz H Egger M Grishina O Finke J;ATG-Fresenius Trial Group 《Blood》2011,117(23):6375-6382
Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we reanalyzed and updated a randomized phase 3 trial comparing standard GVHD prophylaxis with or without pretransplantation ATG-Fresenius (ATG-F) in 201 adult patients receiving myeloablative conditioning before transplantation from unrelated donors. The cumulative incidence of extensive cGVHD after 3 years was 12.2% in the ATG-F group versus 45.0% in the control group (P < .0001). The 3-year cumulative incidence of relapse and of nonrelapse mortality was 32.6% and 19.4% in the ATG-F group and 28.2% and 33.5% in the control group (hazard ratio [HR] = 1.21, P = .47, and HR = 0.68, P = .18), respectively. This nonsignificant reduction in nonrelapse mortality without increased relapse risk led to an overall survival rate after 3 years of 55.2% in the ATG-F group and 43.3% in the control group (HR = 0.84, P = .39, nonsignificant). The HR for receiving immunosuppressive therapy (IST) was 0.31 after ATG-F (P < .0001), and the 3-year probability of survival free of IST was 52.9% and 16.9% in the ATG-F versus control, respectively. The addition of ATG-F to standard cyclosporine, methotrexate GVHD prophylaxis lowers the incidence and severity of cGVHD, and the risk of receiving IST without raising the relapse rate. ATG-F prophylaxis reduces cGVHD morbidity. 相似文献
367.
368.
Heinke J Wehofsits L Zhou Q Zoeller C Baar KM Helbing T Laib A Augustin H Bode C Patterson C Moser M 《Circulation research》2008,103(8):804-812
Bone morphogenetic proteins (BMPs) are involved in embryonic and adult blood vessel formation in health and disease. BMPER (BMP endothelial cell precursor-derived regulator) is a differentially expressed protein in embryonic endothelial precursor cells. In earlier work, we found that BMPER interacts with BMPs and when overexpressed antagonizes their function in embryonic axis formation. In contrast, in a BMPER-deficient zebrafish model, BMPER behaves as a BMP agonist. Furthermore, lack of BMPER induces a vascular phenotype in zebrafish that is driven by disarray of the intersomitic vasculature. Here, we investigate the impact of BMPER on endothelial cell function and signaling and elucidate its role in BMP-4 function in gain- and loss-of-function models. As shown by Western blotting and immunocytochemistry, BMPER is an extracellular matrix protein expressed by endothelial cells in skin, heart, and lung. We show that BMPER is a downstream target of FoxO3a and consistently exerts activating effects on endothelial cell sprouting and migration in vitro and in vivo. Accordingly, when BMPER is depleted from endothelial cells, sprouting is impaired. In terms of BMPER related intracellular signaling, we show that BMPER is permissive and necessary for Smad 1/5 phosphorylation and induces Erk1/2 activation. Most interestingly, BMPER is necessary for BMP-4 to exert its activating role in endothelial function and to induce Smad 1/5 activation. Vice versa, BMP-4 is necessary for BMPER activity. Taken together, BMPER is a dose-dependent endothelial cell activator that plays a unique and pivotal role in fine-tuning BMP activity in angiogenesis. 相似文献
369.
Martin Schneider Dietmar Schranz Ina Michel-Behnke Hellmut Oelert 《Catheterization and cardiovascular interventions》1995,34(1):42-45
In a 3060-g infant with fibromuscular pulmonary atresia an open right ventricular outflow tract was created by means of interventional cardiological methods. Following two inadvertent perforations without sequelae or clinical symptoms, radiofrequency perforation and subsequent balloon dilatation were successfully performed. The implantation of a Palmaz iliac stent led to a predictable communication between the right ventricle and pulmonary artery. 相似文献